I've been taking atomoxetine for almost two years, and I've also done attention training. When can I stop taking the medication?

Nov 21, 2025 Source: Cainiu Health
Dr. Zhang Baohua
Introduction
If symptoms such as inattention, hyperactivity, and impulsivity have been stably controlled for over six months, with daily academic performance and social interaction abilities restored to normal levels, and no mood fluctuations or symptom recurrence occur, the doctor may consider gradually reducing and eventually discontinuing medication. This process should involve slowly tapering the dose over several weeks to months, avoiding abrupt discontinuation that could trigger withdrawal reactions.

Whether to discontinue atomoxetine after nearly two years of use must be determined based on symptom control, functional recovery, and a physician's evaluation—it should not be decided independently. If any abnormalities occur, prompt medical consultation is recommended. The detailed analysis is as follows:

If symptoms such as attention deficit, hyperactivity, and impulsivity have been stably controlled for more than six months, daily academic performance and social interaction abilities have returned to normal levels, and there are no mood fluctuations or symptom relapses, the doctor may consider gradually reducing and eventually discontinuing the medication. This process should take several weeks to months, with slow dose adjustments to avoid withdrawal reactions caused by abrupt discontinuation.

If inattention or frequent hyperactive behaviors persist before stopping the medication, or if symptoms rapidly recur after discontinuation, ongoing treatment remains necessary. Additionally, if severe side effects such as palpitations or insomnia occur during treatment, the medication regimen should be adjusted first rather than stopping the drug outright.

Regular follow-up visits are essential during the discontinuation period to monitor symptom changes and potential drug side effects. Parents should record their child’s daily behavior and maintain communication with the doctor, avoiding any self-directed dosage changes or interruption of treatment.

Related Articles

View All